This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Miltenyi Biotec, Gmbh. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Biography of Inventor Anne Schönbrunn
Introduction: Anne Schönbrunn is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of immunology, particularly in the identification and separation of T-cells.
Latest Patents: Anne holds a patent for a method that identifies and separates non-regulatory T-cells from a mixture of regulatory T-cells. This innovative method utilizes the CD154 molecule (CD40 ligand) to deplete CD154+ T-cells from the mixture. Additionally, it involves the positive selection of regulatory T-cells using specific markers such as CD25, GITR, and CTLA4. The invention also includes a kit that comprises an antibody for detecting CD154 and additional antibodies for detecting activated or non-activated regulatory T-cells.
Career Highlights: Anne Schönbrunn is currently employed at Miltenyi Biotec GmbH, where she continues to advance her research and development efforts in immunology. Her work has garnered attention for its potential applications in therapeutic settings.
Collaborations: Throughout her career, Anne has collaborated with notable colleagues, including Dan Robin Miller and Siegfried Kohler. These partnerships have contributed to the success and impact of her research.
Conclusion: Anne Schönbrunn is a trailblazer in her field, with a focus on innovative methods for T-cell identification and separation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile